Oct 24 (Reuters) - Laboratory operator Labcorp (LH.N), opens new tab beat Wall Street estimates for third-quarter profit and revenue on Thursday as strong demand for diagnostic tests offset a hit from ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Here's how Labcorp, the ...

Labcorp Holdings reported robust financial results for the third quarter of 2025, with adjusted earnings per share (EPS) surpassing expectations and revenue meeting forecasts. The company recorded an ...

Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.

Labcorp delivered mixed third-quarter results, with higher sales and raised profit guidance but a lower full-year revenue forecast as it “takes action” on an underperforming unit. First, overall sales ...